Inhibitory and combinatorial effect of diphyllin, a v-ATPase blocker, on influenza viruses.
Inhibitory and combinatorial effect of diphyllin, a v-ATPase blocker, on influenza viruses.
复制标题
DOI:
10.1016/j.antiviral.2013.06.014
复制
发表时间:
2013-09
影响因子:
7.6
通讯作者:
Liu, Yu-Tsueng
中科院分区:
文献类型:
--
作者:
Chen, Hui-Wen;Cheng, Jenna Xiao;Liu, Ming-Tsan;King, Kevin;Peng, Ju-Yi;Zhang, Xin-Quan;Wang, Ching-Ho;Shresta, Sujan;Schooley, Robert T.;Liu, Yu-Tsueng
Diphyllin inhibits endosomal acidification in MDCK cells and A549 cells. Treatment with diphyllin alters the cellular susceptibility to the influenza virus. Diphyllin demonstrated a broad-spectrum antiviral activity. The combination of diphyllin and other drugs showed an enhanced antiviral effect. An influenza pandemic poses a serious threat to humans and animals. Conventional treatments against influenza include two classes of pathogen-targeting antivirals: M2 ion channel blockers (such as amantadine) and neuraminidase inhibitors (such as oseltamivir). Examination of the mechanism of influenza viral infection has shown that endosomal acidification plays a major role in facilitating the fusion between viral and endosomal membranes. This pathway has led to investigations on vacuolar ATPase (v-ATPase) activity, whose role as a regulating factor on influenza virus replication has been verified in extensive genome-wide screenings. Blocking v-ATPase activity thus presents the opportunity to interfere with influenza viral infection by preventing the pH-dependent membrane fusion between endosomes and virions. This study aims to apply diphyllin, a natural compound shown to be as a novel v-ATPase inhibitor, as a potential antiviral for various influenza virus strains using cell-based assays. The results show that diphyllin alters cellular susceptibility to influenza viruses through the inhibition of endosomal acidification, thus interfering with downstream virus replication, including that of known drug-resistant strains. In addition, combinatorial treatment of the host-targeting diphyllin with pathogen-targeting therapeutics (oseltamivir and amantadine) demonstrates enhanced antiviral effects and cell protection in vitro.
登录
查看更多内容
影响因子:
5.4
作者:
GUINEA, R;CARRASCO, L
通讯作者:
CARRASCO, L
影响因子:
--
作者:
Niikura, Kazuaki
通讯作者:
Niikura, Kazuaki
影响因子:
3.6
作者:
Charlton, JL;Oleschuk, CJ;Chee, GL
通讯作者:
Chee, GL
影响因子:
7.6
作者:
Lee SM;Yen HL
通讯作者:
Yen HL
影响因子:
64.8
作者:
通讯作者:
--